Romeo Puzon
General Practice · Lakewood, WANPI 1538190608
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 275 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $36.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- AstraZeneca$1K
- Otsuka America Pharmaceutical, Inc.$446
- Mayne Pharma Commercial LLC$429
- Amgen$405
- plus $4K from 33 others
Across 1 payment — averaging $150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$150
What the payments were for
- Food & beverage$10,149100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $2,348 |
| Johnson & Johnson | 27 | $1,325 |
| AstraZeneca | 22 | $1,288 |
| Otsuka America Pharmaceutical, Inc. | 18 | $446 |
| Mayne Pharma Commercial LLC | 7 | $429 |
| Amgen | 9 | $405 |
| Novo Nordisk | 6 | $312 |
| Amarin Pharma, Inc. | 10 | $304 |
| GSK | 7 | $273 |
| Neurocrine Biosciences, Inc. | 7 | $223 |
| Bayer | 5 | $220 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $194 |
| Pfizer | 5 | $193 |
| Zyla Life Sciences, Inc. | 11 | $181 |
| Braeburn Inc. | 4 | $174 |
| Kowa Pharmaceuticals America, Inc. | 8 | $168 |
| Teva Pharmaceuticals USA, Inc. | 3 | $149 |
| Biohaven Pharmaceuticals, Inc. | 3 | $148 |
| Lilly USA, LLC | 6 | $144 |
| Boehringer Ingelheim | 2 | $140 |
| Seqirus USA Inc | 5 | $127 |
| Assertio Therapeutics, Inc. | 7 | $110 |
| Merck | 2 | $108 |
| Indivior Inc. | 5 | $93 |
| Aurinia Pharma U.S., Inc. | 1 | $86 |
| Exact Sciences | 3 | $82 |
| Lundbeck LLC | 3 | $82 |
| Genentech USA, Inc. | 2 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $65 |
| Sunovion Pharmaceuticals Inc. | 3 | $64 |
| Medicomp Inc | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $29 |
| Mimedx Group, Inc. | 1 | $28 |
| Nevro Corp. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Gilead | 1 | $15 |
| Orexo US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,169 in reported general payments places this provider in the 95th percentile of 2,229 general practice providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 36 | $4,626 |
| Buprenorphine Hcl | 14 | $1,541 |
Paid to pharmacies, not to this prescriber.
Other general practice in Lakewood
- Bret JacobsonFederal Way$690K
- Bill WongBellevue$567K
- Michael SilvermanSeattle$252K
- Michael KocejaVancouver$103K
- Owen JohnsonTacoma$69K
- Perry Jones IiiSeattle$67K
- Kevin BrownBellevue$64K
- Mike ClarkYakima$44K
- John HodgesCovington$41K
- Michael MelkersSpokane Valley$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.